Cite
HARVARD Citation
Tan, H. et al. (2017). Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis. Journal of dermatological treatment. pp. 3-7. [Online].